Stay updated on Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial

Sign up to get notified when there's something new on the Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The clinical-trial page now presents the GMMG HD7 study record instead of a forbidden-access error. It describes the trial’s isatuximab treatment strategies for newly diagnosed multiple myeloma, along with study design, eligibility, outcomes, and participating locations.
    Difference
    90%
    Check dated 2026-11-11T20:52:26.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T23:23:17.000Z thumbnail image
  3. Check
    24 days ago
    Change Detected
    Summary
    A notice banner appears above the page, announcing NIH’s transition-related updates and use of “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-21T22:07:01.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-14T22:13:06.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1, while the study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T22:20:04.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error for the study record, replacing the expected content with an access-denied message. The visible layout includes the header and footer but no study details, indicating an error state rather than new or updated study information.
    Difference
    19%
    Check dated 2026-09-23T22:10:18.000Z thumbnail image

Stay in the know with updates to Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Isatuximab in RVd Induction and Lenalidomide Maintenance Clinical Trial page.